Pollution prevention assessment for a manufacturer of pharmaceuticals
Read Online

Pollution prevention assessment for a manufacturer of pharmaceuticals by Harry W. Edwards

  • 59 Want to read
  • ·
  • 8 Currently reading

Published by U.S. Environmental Protection Agency, National Risk Management Research Laboratory in Cincinnati, OH .
Written in English


  • Pharmaceutical industry -- Waste disposal -- Environmental aspects -- United States

Book details:

Edition Notes

StatementHarry W. Edwards, Michael F. Kostrzewa, and Gwen P. Looby
SeriesEnvironmental research brief
ContributionsKostrzewa, Michael F, Looby, Gwen P, National Risk Management Research Laboratory (U.S.)
The Physical Object
Pagination5 p. :
ID Numbers
Open LibraryOL14986013M

Download Pollution prevention assessment for a manufacturer of pharmaceuticals


  It includes case studies from several industries, such as pharmaceuticals, pesticides, metals, electronics, petrochemicals, refineries, and more. It also addresses the . Pollution prevention assessment for a manufacturer of pharmaceuticals by Harry W Edwards (Book) 3 editions published Pollution prevention . Compliance with environmental and occupational safety and health laws is the responsibility of each individual business and is not the focus of this document. The environmental impact of industrial waste is one of the most serious challenges facing the chemical process industries. From a focus on end-of-pipe treatment in the Reviews: 1.

to pretreatment and discharge of effluent, discharge and pollution prevention of oil, and designation of hazardous substances and reportable quantities. This manual . The assessment of the environmental risks covers only a minority of pharmaceuticals. and to control emissions of pharmaceuticals to the environment when . pharmaceuticals in the environment (in journals and books) had increased yearly — from a rate of per year to a rate of per year. Daughton et al. () . Pollution Prevention Assessment for a Manufacturer of Combustion Engine Piston Rings rg 8 ;z P,I E v ED Richard J. Jendrucko., Todd M. Thomas’, and Gwen P.

vironmental assessment (EA) process on the ba-sis of country legislation and the. Pollution Prevention and Abatement Handbook, as applied to local con-ditions. The emissions levels selected must be justified in the EA and acceptable to the World Bank Group. The following guidelines present emissions levels normally acceptable to the World Bank. The manufacture of pharmaceuticals is controlled by Good Management Practices (GMP) in some countries (for example, refer to Her Majesty's Inspectorate of Pollution, ) and some countries require an environmental assessment (EA) report addressing the fate and toxicity of drugs and their metabolized by-products. This Pollution Prevention Program Area contains guidance, tools, examples, and analyses of products and processes which can be substituted for existing products/processes or added to existing processes to reduce/eliminate pollution. These tools, examples, products, and processes are all aids to meeting the EO goals. Article Pharmaceuticals Manufacturing Industry - Pollution Prevention Guidelines. Introduction Pollution Prevention Guidelines to provide technical advice and guidance to staff and consultants involved in pollution-related projects. The guidelines.